These mutations are more common in men with early-onset PC arising due to congenital defects in response to oxidative stress (e.g., NKX3.1) or DNA damage repair mechanisms (BRCA2); therefore, they may predict a more aggressive course of the disease. This evidence concerns the gene BRCA2 and pachyonychia congenita.